Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-20T00:31:31.348Z Has data issue: false hasContentIssue false
  • English
  • Français

Meeting the Challenges of International Crises: The Experience of the Iranian Blood Transfusion Organization

Published online by Cambridge University Press:  01 August 2018

Nasim Sadat Hosseini Divkolaye ,
Fariba Seighali ,
Ali Akbar Pourfathollah ,
Mitra Radfar  and
Frederick M. Burkle Jr
Nasim Sadat Hosseini Divkolaye
Affiliation:
International Affairs Department, Iranian Blood Transfusion Organization, Tehran, Iran Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom
Fariba Seighali*
Affiliation:
Blood Transfusion Research Center, High Institute for Research & Education on Transfusion Medicine, Tehran, Iran
Ali Akbar Pourfathollah
Affiliation:
Blood Transfusion Research Center, High Institute for Research & Education on Transfusion Medicine, Tehran, Iran Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Mitra Radfar
Affiliation:
Department of Pediatrics, Shahid Beheshti Medical University, Tehran, Iran
Frederick M. Burkle Jr
Affiliation:
Harvard Humanitarian Initiative, Harvard University, Cambridge, Massachusetts The Woodrow Wilson International Center for Scholars, Washington, DC
*
Correspondence and reprint requests to Fariba Seighali, Blood Transfusion Research Center, High Institute for Research & Education in Transfusion Medicine, Postal Box 146651157, IBTO BLDG, Hemmat EXPY, Adjacent to Milad Tower, Tehran, Iran (e-mail: [email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

Crises require a timely and well-prepared response by health services, especially those that are directly engaged with the lives of the patients such as blood services. The Iranian Blood Transfusion Organization as a single national authority of blood transfusion has left many crises behind. In this study, we examined the main international crises that the blood transfusion organization has faced during its 44-year history and objectively evaluated the methods for crisis risk reduction, both administrative and operational, all of which have led to fundamental advances in the organization. By proper planning and effective strategy setting, the Iranian Blood Transfusion Organization has managed to cope with international threats and in some cases has turned threats into opportunities to implement new, permanent administrative and operational strategies. It is not prudent for blood transfusion centers to develop their disaster risk reduction strategies on an individual-country basis in a world where global risk and crisis factors are rapidly increasing. Reduction of risk for blood transfusion centers must become a strategic priority nationally and globally. (Disaster Med Public Health Preparedness. 2019;13:410-413)

Keywords

blood transfusionblood donationcrisis managementdisaster medicineIran-Iraq WarHIVhepatitisrecruitment campaign
Type
Brief Report
Information
Disaster Medicine and Public Health Preparedness , Volume 13 , Issue 3 , June 2019 , pp. 410 - 413
Copyright
Copyright © 2018 Society for Disaster Medicine and Public Health, Inc. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. World Health Organization. Risk reduction and emergency preparedness. WHO Six-Year Strategy for the Health Sector and Community Capacity Development. http://www.who.int/hac/techguidance/preparedness/emergency_preparedness_eng.pdf (1 .07.2011). Published 2007. Accessed August 28, 2017.Google Scholar
2. World Health Organization. International Crises. http://www.who.int/hac/crises/international/en/. Accessed August 28, 2017.Google Scholar
3. Bundy, J, Pfarrer, MD, Short, CE, et al. Crises and crisis management: integration, interpretation, and research development. J Manag. 2016;43(6):1661-1692.Google Scholar
4. Pourfathollah, AA, Hosseini Divkolaye, NS, Seighali, F. Four decades of National Blood Service in Iran: outreach, prospect and challenges. Transfus Med. 2015 Jun 25 (3):138-143.Google Scholar
5. Abolghasemi, H, Maghsudlu, M, Amini Kafi-Abad, S, et al. Introduction to Iranian Blood Transfusion Organization and Blood Safety in Iran. Iran J Public Health. 2009;38(suppl 1):82-87.Google Scholar
6. Maghsudlu, M, Nasizadeh, S, Abolghasemi, H, et al. Blood donation and donor recruitment in Iran from 1998 through 2007: ten years’ experience. Transfusion. 2009 Nov 49 (11):2346-2351.Google Scholar
7. Angelotta, C, McKoy, JM, Fisher, MJ, et al. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia. Vox Sang. 2007 Aug 93 (2):159-165.Google Scholar
8. Cheraghali, AM, Eshghi, P, Abolghasemi, H. Social consequences of infected haemophilia cases in the Islamic Republic of Iran. East Mediterr Health J. 2011 Jun 17 (6):552-556.Google Scholar
9. World Health Organization. Improving Access to Safe Blood Products Through Local Production and Technology Transfer in Blood Establishments. http://www.who.int/phi/publications/blood-prods_technology_transfer.pdf. Published 2015. Accessed August 28, 2017.Google Scholar
10. Cheraghali, AM. Cost effectiveness of Iran national plasma contract fractionation program. Daru. 2012;20(1):63. doi: 10.1186/2008-2231-20-63.Google Scholar
11. The Impact of Sanctions on the Iranian People’s Healthcare System. International Institute for Peace, Justice and Human Rights. http://www.globalresearch.ca/the-impact-of-sanctions-on-the-iranian-peoples-healthcare-system/5354773. Published 2013. Accessed August 28, 2017.Google Scholar
12. The Islamic Republic News Agency. IBTO Managing Director: 100% Blood Bag From Domestic Products. http://www.irna.ir/fa/News/82443493. Published February 25, 2017. Accessed August 28, 2017.Google Scholar
13. Fidler, D, Drager, N. Global Health and foreign policy: strategic opportunities and challenges. World Health Organization. http://www.who.int/trade/events/UNGA_Background_Rep3_2.pdf. Published May 11, 2009. Accessed August 28, 2017.Google Scholar